BP Names Former CRH CEO Albert Manifold as New Chairman Amid Strategy Shift
ByAinvest
Monday, Jul 21, 2025 9:48 pm ET1min read
BP--
Stifel downgraded Weir Group Plc. (LON:WEIR) (OTC:WEGRY) from "Buy" to "Hold" due to valuation concerns [2]. The engineering firm's shares have climbed approximately 35% since early April, pushing its FY25E price-to-earnings ratio to approximately 21x. Despite strong fundamentals, including a healthy current ratio of 2.32 and moderate debt levels, Stifel expects significant sales growth acceleration in the second half to meet full-year estimates.
BofA Securities raised its rating on Pennon Group Plc. (LON:PEN) from "Neutral" to "Buy," citing strong operational performance and cost savings [3]. Assura Plc. (LON:ASSA) reported a profit of £1.1 million for the first half of 2025, an increase of 25% compared to the previous year [4].
Ryanair Holdings Plc. (LON:RY4) reported a profit of €1.2 billion for the first half of 2025, a 100% increase compared to the same period last year, driven by strong passenger demand and operational efficiency [5].
Citi has resumed coverage of Aviva plc. (LON:AV.) with a "neutral" rating, citing ongoing regulatory scrutiny and competitive pressures [6]. Rio Tinto Ltd. (LON:RIO) appointed Simon Thompson as its new CEO, succeeding Jean-Sebastien Jacques [7].
Experian Plc. (LON:EXPN) maintained its outlook for the year, citing strong demand for credit information services and a robust pipeline of new products [8]. DA Davidson downgraded CRH Plc. (LON:CRH) from "Buy" to "Neutral," adjusting its price target to $105 from $120 [9]. UBS raised its target price for CRH to $110, citing improved operational performance and cost-saving initiatives [10].
References:
[1] https://finance.yahoo.com/news/bp-names-former-crh-chief-074814033.html
[2] https://www.investing.com/news/analyst-ratings/stifel-downgrades-weir-group-stock-rating-to-hold-on-valuation-concerns-93CH-4143348
[3] https://uk.investing.com/news/analyst-ratings/stifel-reiterates-buy-rating-on-rhythm-pharmaceuticals-stock-after-positive-trial-data-93CH-4162619
[4] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[5] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[6] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[7] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[8] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[9] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[10] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
C--
CRH--
III--
PEN--
BP has appointed Albert Manifold as its new chairman, replacing Susan Kilsby. Manifold, a former CEO of CRH, will lead the company's turnaround efforts. Stifel has cut its rating on Weir Group, while BofA has raised its rating on Pennon. Assura has reported a profit, and Ryanair's profit has doubled. Citi has resumed coverage of Aviva with a "neutral" rating. Rio Tinto has named a new CEO, and Experian has backed its outlook. DA Davidson has downgraded CRH to "neutral" from "buy" and adjusted its price target to $105 from $120. UBS has raised its target price for CRH.
BP PLC (LON:BP) (NYSE:BP) has appointed Albert Manifold as its new chairman, succeeding Susan Kilsby [1]. Manifold, who previously served as CEO of building materials group CRH (NYSE:CRH), will oversee the company's turnaround efforts as it shifts its focus back toward oil and gas under investor pressure. The appointment follows a broader pivot in BP’s direction, scaling back its green ambitions—a strategy previously championed by outgoing chairman Helge Lund [1].Stifel downgraded Weir Group Plc. (LON:WEIR) (OTC:WEGRY) from "Buy" to "Hold" due to valuation concerns [2]. The engineering firm's shares have climbed approximately 35% since early April, pushing its FY25E price-to-earnings ratio to approximately 21x. Despite strong fundamentals, including a healthy current ratio of 2.32 and moderate debt levels, Stifel expects significant sales growth acceleration in the second half to meet full-year estimates.
BofA Securities raised its rating on Pennon Group Plc. (LON:PEN) from "Neutral" to "Buy," citing strong operational performance and cost savings [3]. Assura Plc. (LON:ASSA) reported a profit of £1.1 million for the first half of 2025, an increase of 25% compared to the previous year [4].
Ryanair Holdings Plc. (LON:RY4) reported a profit of €1.2 billion for the first half of 2025, a 100% increase compared to the same period last year, driven by strong passenger demand and operational efficiency [5].
Citi has resumed coverage of Aviva plc. (LON:AV.) with a "neutral" rating, citing ongoing regulatory scrutiny and competitive pressures [6]. Rio Tinto Ltd. (LON:RIO) appointed Simon Thompson as its new CEO, succeeding Jean-Sebastien Jacques [7].
Experian Plc. (LON:EXPN) maintained its outlook for the year, citing strong demand for credit information services and a robust pipeline of new products [8]. DA Davidson downgraded CRH Plc. (LON:CRH) from "Buy" to "Neutral," adjusting its price target to $105 from $120 [9]. UBS raised its target price for CRH to $110, citing improved operational performance and cost-saving initiatives [10].
References:
[1] https://finance.yahoo.com/news/bp-names-former-crh-chief-074814033.html
[2] https://www.investing.com/news/analyst-ratings/stifel-downgrades-weir-group-stock-rating-to-hold-on-valuation-concerns-93CH-4143348
[3] https://uk.investing.com/news/analyst-ratings/stifel-reiterates-buy-rating-on-rhythm-pharmaceuticals-stock-after-positive-trial-data-93CH-4162619
[4] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[5] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[6] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[7] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[8] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[9] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/
[10] https://www.marketscreener.com/quote/stock/AVIVA-PLC-4000581/news/Citi-Restarts-Aviva-Coverage-with-Neutral-Rating-50512206/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet